
TY  - JOUR
TI  - Invited Speakers
JO  - Australasian Journal on Ageing
JA  - Australas J Ageing
VL  - 38
IS  - S1
SN  - 1440-6381
UR  - https://doi.org/10.1111/ajag.12659
DO  - doi:10.1111/ajag.12659
SP  - 13
EP  - 17
PY  - 2019
ER  - 

TY  - JOUR
TI  - 2013 ACVIM Forum Research Abstracts Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 27
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.12100
DO  - doi:10.1111/jvim.12100
SP  - 604
EP  - 756
PY  - 2013
ER  - 

TY  - JOUR
AU  - Alhamdi, Yasir
AU  - Toh, Cheng-Hock
TI  - The role of extracellular histones in haematological disorders
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 173
IS  - 5
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.14077
DO  - doi:10.1111/bjh.14077
SP  - 805
EP  - 811
KW  - extracellular histones
KW  - nucleosomes
KW  - neutrophil extracellular traps
KW  - cell death
KW  - thrombin
PY  - 2016
AB  - Summary Over the past decades, chromosomal alterations have been extensively investigated for their pathophysiological relevance in haematological malignancies. In particular, epigenetic modifications of intra-nuclear histones are now known as key regulators of healthy cell cycles that have also evolved into novel therapeutic targets for certain blood cancers. Thus, for most haematologists, histones are DNA-chained proteins that are buried deep within chromatin. However, the plot has deepened with recent revelations on the function of histones when unchained and released extracellularly upon cell death or from activated neutrophils as part of neutrophil extracellular traps (NETs). Extracellular histones and NETs are increasingly recognized for profound cytotoxicity and pro-coagulant effects. This article highlights the importance of recognizing this new paradigm of extracellular histones as a key player in host defence through its damage-associated molecular patterns, which could translate into novel diagnostic and therapeutic biomarkers in various haematological and critical disorders.
ER  - 

AU  - Lunn, Michael
AU  - Hanna, Michael
AU  - Howard, Robin
AU  - Parton, Matthew
AU  - Reilly, Mary
C7  - pp. 337-410
TI  - Nerve and Muscle Disease
SN  - 9781405134439
UR  - https://doi.org/10.1002/9781444311709.ch9
DO  - doi:10.1002/9781444311709.ch9
SP  - 337-410
KW  - nerve and muscle disease
KW  - inherited neuropathies
KW  - classification of inherited neuropathies
KW  - chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
KW  - focal and compressive neuropathies
KW  - hereditary neuropathy
PY  - 2016
AB  - Summary This chapter contains sections titled: Peripheral nerve disorders Diseases of the peripheral nerve Inherited neuropathies Acquired neuropathies Focal and compressive neuropathies Anterior horn cell diseases Spinal muscular atrophy Disorders of the neuromuscular junction Muscle diseases References
ER  - 

TY  - JOUR
AU  - Assali, Abid
AU  - Vaknin-Assa, Hana
AU  - Lev, Eli
AU  - Bental, Tamir
AU  - Ben-Dor, Itsik
AU  - Teplitsky, Igal
AU  - Brosh, David
AU  - Fuchs, Shmuel
AU  - Eidelman, Leonid
AU  - Battler, Alexander
AU  - Kornowski, Ran
TI  - The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery
JO  - Catheterization and Cardiovascular Interventions
JA  - Cathet. Cardiovasc. Intervent.
VL  - 74
IS  - 6
SN  - 9781405134439
UR  - https://doi.org/10.1002/ccd.22158
DO  - doi:10.1002/ccd.22158
SP  - 837
EP  - 843
KW  - noncardiac surgery
KW  - drug-eluting stent
KW  - stent thrombosis
PY  - 2009
AB  - Abstract Aims: Given the anecdotal reports and case series suggesting that drug-eluting coronary stents [DES] may be still vulnerable to coronary thrombosis after six months, we sought to assess this risk in patients undergoing non-cardiac surgery six months after stenting. Methods and Results: Linking the Rabin Medical Centre interventional cardiology database with its non-cardiac surgical database, we identified 78 patients who underwent DES placement and subsequently [after six months] had noncardiac surgery [15-vascular, 37- abdominal and genitourinary and 26-others, excluding ophthalmic surgery]. Outcome measures included 30-day rate of postoperative myocardial infarction (MI), DES-related thrombosis, and cardiac mortality. Major adverse cardiac events [death and non-fatal MI] occurred in 6 (7.7%) patients including 2 cardiac deaths (2.6%), 4 (5.1%) non-fatal myocardial infarctions (MIs). Two patients (2.6%) sustained stent thrombosis [one patient had ?definite? and one ?probable? stent thrombosis]. All MIs [including stent thrombosis] occurred in the vascular and abdominal surgery group. Two of the MIs events occurred while the patients were on dual antiplatelet agents. In conclusions: Perioperative cardiac events during non cardiac surgery after six months of DES deployment still occur. These cardiac complications [not entirely prevented by continued dual antiplatelet agents] remain a matter of diagnostic and therapeutic challenge and concern. ? 2009 Wiley-Liss, Inc.
ER  - 

C7  - pp. 27-119
TI  - Conditions
SN  - 9781119117117
UR  - https://doi.org/10.1002/9781119548553.ch2
DO  - doi:10.1002/9781119548553.ch2
SP  - 27-119
KW  - acute coronary syndromes
KW  - adult nursing
KW  - breast lumps
KW  - dementias
KW  - encephalitis
KW  - hepatitis
KW  - leukaemias
KW  - osteoarthritis
KW  - respiratory failure
KW  - urinary retention
PY  - 2009
AB  - Summary Adult nursing comprises the skilled, dignified care of adults. It focuses on acute and chronic physical conditions rather than mental illness. This chapter discusses the definition, diagnosis and investigations, screening, common signs and symptoms, treatment, and nursing care of various diseases such as, acute coronary syndromes, acute renal failure, anaemias, aneurysms, breast lumps, breathlessness, cancer, cardiovascular disorders, cataracts, and cholecystitis, chronic obstructive pulmonary disease, dementias, diabetes mellitus, diarrhea, diverticular disease, eczema, encephalitis, endocrine disorders. The other diseases include fractures, gallstone disease, gastritis, gastroenteritis, gastro-oesophageal reflux disease, glaucoma, glomerulonephritis, gout, haemorrhoids, hearing loss, heart failure, hepatitis, HIV, hypertension, hysterectomy, immunodeficiency, incontinence, jaundice, leukaemias, life support: advanced adult, and life support: basic adult,. The remaining diseases include macular degeneration, meningitis, multiple sclerosis, myopathies, nausea and vomiting, neutropenia, osteoarthritis, osteomyelitis, osteoporosis, pain and discomfort, pancreatitis, and Parkinson's disease, respiratory failure, sepsis, tuberculosis, urethritis, urinary retention, valve disease, and vascular disorders of the brain.
ER  - 

TY  - JOUR
TI  - Papers contents list
JO  - BJU International
VL  - 99
IS  - s4
SN  - 9781119117117
UR  - https://doi.org/10.1111/j.1464-410X.2007.06885.x
DO  - doi:10.1111/j.1464-410X.2007.06885.x
SP  - 1
EP  - 15
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Internal Medicine Journal
VL  - 40
IS  - s1
SN  - 9781119117117
UR  - https://doi.org/10.1111/j.1445-5994.2010.02187.x
DO  - doi:10.1111/j.1445-5994.2010.02187.x
SP  - 66
EP  - 185
PY  - 2010
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 26th Annual ACVIM Forum San Antonio, TX, June 4 – June 7, 2008
JO  - Journal of Veterinary Internal Medicine
VL  - 22
IS  - 3
SN  - 9781119117117
UR  - https://doi.org/10.1111/j.1939-1676.2008.0103.x
DO  - doi:10.1111/j.1939-1676.2008.0103.x
SP  - 687
EP  - 824
PY  - 2008
ER  - 

AU  - Prandoni, Paolo
C7  - pp. 27-52
TI  - The Natural History of Venous Thromboembolism
SN  - 9780470517178
UR  - https://doi.org/10.1002/9780470745007.ch2
DO  - doi:10.1002/9780470745007.ch2
SP  - 27-52
KW  - venous thromboembolism
KW  - deep vein thrombosis
KW  - pulmonary embolism
KW  - anticoagulation
KW  - thrombophilia
KW  - post-thrombotic syndrome
KW  - chronic thromboembolic pulmonary hypertension
KW  - cancer
KW  - atherosclerosis
PY  - 2008
AB  - Summary In contrast with the extensive and uniform documentation dealing with the short-term outcome of the deep vein thrombosis (DVT) of the lower extremities and of pulmonary embolism (PE), sparse and conflicting results are available concerning the long-term clinical course of these diseases. The natural history of venous thromboembolism (VTE) includes the risk of death, which often complicates the evolution of patients with severe or misclassified PE; the risk of recurrent events, which is particularly common in patients with DVT involving the proximal vein system with or without contemporary manifestations of PE; the risk of long-term sequelae, namely the post-thrombotic syndrome in patients with DVT, and the chronic thromboembolic pulmonary hypertension in those presenting with PE; the risk of subsequent overt cancer, which is particularly frequent in the first months following an episode of unprovoked VTE; and the risk of arterial cardiovascular events, which is more common in the first year after the thrombotic episode but persists, although to a lesser extent, for longer periods of time. In this chapter, factors than can help predict the development of these complications in patients with VTE are extensively analysed.
ER  - 

AU  - Shephard, Mark
AU  - Motta, Lara
AU  - Spaeth, Brooke
AU  - Halls, Heather
AU  - Duckworth, Lauren
C7  - pp. 245-269
TI  - Point-of-Care Testing for Blood Counts, HbA1c, Renal Function, Electrolytes, Acid–Base Balance and Hepatitis
SN  - 9781119282648
UR  - https://doi.org/10.1002/9781119282686.ch16
DO  - doi:10.1002/9781119282686.ch16
SP  - 245-269
KW  - point-of-care testing
KW  - POC testing
KW  - blood counts
KW  - blood sugar levels
KW  - HbA1c
KW  - renal function
KW  - electrolytes and acid–base balance
KW  - hepatitis
KW  - remote rural impoverished areas
KW  - developing world
KW  - developing nations
KW  - developing nations
KW  - low- to middle-income countries
KW  - LMICs
KW  - tropical disease
KW  - diseases in the tropics
PY  - 2008
AB  - Chapter menu 16.1 Introduction 16.2 Point-of-Care Testing for Blood Counts 16.2.1. Clinical Use of Blood Counts 16.2.2. POC Testing Device Options for Hemoglobin Estimation 16.2.3. POC Testing Device Options for Full Blood Count Estimation 16.2.4. A Case Study Illustrating the Value of POC Testing for White Blood Cell Counts 16.2.5. Presentation/History 16.2.6. Examinations 16.2.7. Treatment/Follow-up 16.2.8. Outcome 16.2.9. Summary 16.3 Point-of-Care Testing for HbA1c 16.3.1. Clinical Use of Hemoglobin A1c 16.3.2. POC Testing Device Options for Measuring HbA1c 16.3.3. An Example of a POC Testing Model with Application in the LMICs 16.4 Point-of-Care Testing for Renal Function 16.4.1.Clinical Summary 16.4.2.POC Testing Device Options for Creatinine 16.4.3.POC Testing Device Options for Urine Albumin 16.4.4.A Case Study Illustrating the Value of POC Testing for Renal Function 16.4.5.Presentation 16.4.6.POC Testing Performed 16.4.7.Diagnosis 16.4.8.Treatment/Follow-up 16.4.9. Outcome 16.4.10. Summary 16.5 Point-of-Care Testing for Electrolytes and Acid?Base Balance 16.5.1. Clinical Use of Tests for Electrolytes and Acid?Base Balance 16.5.2. POC Testing Device Options for Electrolyte Profile and Acid?Base Balance 16.6 Point-of-Care Testing for Hepatitis 16.6.1. Clinical Use of Hepatitis Testing 16.6.2. Pathology Tests for Hepatitis 16.6.3. POC Testing for Hepatitis B 16.6.4. POC Testing for Hepatitis C 16.7 Conclusions Bibliography
ER  - 

TY  - JOUR
TI  - ACVIM Forum Abstracts
JO  - Journal of Veterinary Internal Medicine
VL  - 21
IS  - 3
SN  - 9781119282648
UR  - https://doi.org/10.1111/j.1939-1676.2007.tb03006.x
DO  - doi:10.1111/j.1939-1676.2007.tb03006.x
SP  - 559
EP  - 670
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Thrombosis and Haemostasis
JA  - J Thromb Haemost
VL  - 13
IS  - S2
SN  - 9781119282648
UR  - https://doi.org/10.1111/jth.12993
DO  - doi:10.1111/jth.12993
SP  - 1
EP  - 997
PY  - 2015
ER  - 

TY  - JOUR
TI  - Thursday, 28 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 9781119282648
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_4.x
DO  - doi:10.1111/j.1538-7836.2011.04380_4.x
SP  - 712
EP  - 959
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts From the 8th International Conference on Pediatric Mechanical Circulatory Support Systems & Pediatric Cardiopulmonary Perfusion
JO  - Artificial Organs
VL  - 36
IS  - 5
SN  - 9781119282648
UR  - https://doi.org/10.1111/j.1525-1594.2012.01477.x
DO  - doi:10.1111/j.1525-1594.2012.01477.x
SP  - A1
EP  - A29
PY  - 2012
ER  - 

TY  - JOUR
TI  - Workshops
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 46
IS  - S1
SN  - 9781119282648
UR  - https://doi.org/10.1111/eci.12604
DO  - doi:10.1111/eci.12604
SP  - 6
EP  - 119
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Research and Practice in Thrombosis and Haemostasis
JA  - Res Pract Thromb Haemost
VL  - 1
IS  - S1
SN  - 9781119282648
UR  - https://doi.org/10.1002/rth2.12012
DO  - doi:10.1002/rth2.12012
SP  - 1
EP  - 1451
PY  - 2017
ER  - 

TY  - JOUR
TI  - Acute coronary syndromes, myocardial infarction, thrombectomy and vulnerable plaque
JO  - Catheterization and Cardiovascular Interventions
JA  - Cathet. Cardiovasc. Intervent.
VL  - 85
IS  - S2
SN  - 9781119282648
UR  - https://doi.org/10.1002/ccd.25910
DO  - doi:10.1002/ccd.25910
SP  - S1
EP  - S176
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 60
IS  - s4
SN  - 9781119282648
UR  - https://doi.org/10.1111/j.1532-5415.2012.04000.x
DO  - doi:10.1111/j.1532-5415.2012.04000.x
SP  - S1
EP  - S242
PY  - 2012
ER  - 

AU  - Buttaro, Terry Mahan
C7  - pp. 79-123
TI  - Cardiovascular Disorders
SN  - 9780813810461
UR  - https://doi.org/10.1002/9781118704769.ch4
DO  - doi:10.1002/9781118704769.ch4
SP  - 79-123
KW  - Acute coronary syndrome (ACS)
KW  - Atrial fibrillation (AF)
KW  - Cardiovascular disorders
KW  - Coronary artery disease (CAD)
KW  - Heart failure
KW  - Heart valve disease
KW  - Hypertension
KW  - Peripheral vascular disease (PVD)
KW  - Pharmacologic therapy
KW  - Venous thromboembolism (VTE)
PY  - 2012
AB  - Summary This chapter contains sections titled: Part 1 Acute Coronary Syndrome Part 2 Atrial Fibrillation Part 3 Venous Thromboembolism Part 4 Heart Failure Part 5 Hypertension Part 6 Peripheral Vascular Disease Part 7 Heart Valve Disease
ER  - 
